Andrew Fein
Stock Analyst at HC Wainwright & Co.
(3.32)
# 1,009
Out of 4,711 analysts
541
Total ratings
40.64%
Success rate
4.61%
Average return
Main Sectors:
Stocks Rated by Andrew Fein
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GPCR Structure Therapeutics | Reiterates: Buy | $80 | $27.90 | +186.74% | 3 | Dec 20, 2024 | |
| PRTA Prothena Corporation | Reiterates: Buy | $84 → $48 | $15.22 | +215.37% | 14 | Dec 20, 2024 | |
| VRTX Vertex Pharmaceuticals | Maintains: Buy | $600 → $535 | $397.27 | +34.67% | 24 | Dec 20, 2024 | |
| RNA Avidity Biosciences | Initiates: Buy | $72 | $31.82 | +126.27% | 1 | Dec 20, 2024 | |
| FHTX Foghorn Therapeutics | Reiterates: Buy | $20 → $13 | $5.14 | +152.92% | 13 | Dec 17, 2024 | |
| ANNX Annexon | Reiterates: Buy | $30 | $5.23 | +473.61% | 14 | Dec 17, 2024 | |
| NBIX Neurocrine Biosciences | Reiterates: Buy | $190 | $135.42 | +40.30% | 15 | Dec 16, 2024 | |
| KROS Keros Therapeutics | Reiterates: Buy | $100 → $47 | $17.03 | +175.98% | 12 | Dec 13, 2024 | |
| PRQR ProQR Therapeutics | Reiterates: Buy | $10 | $2.63 | +280.23% | 11 | Dec 12, 2024 | |
| TCRX TScan Therapeutics | Reiterates: Buy | $15 | $2.97 | +405.05% | 12 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $87 | $18.48 | +370.78% | 15 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $23 | $5.39 | +326.72% | 13 | Dec 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $20 | $8.36 | +139.23% | 13 | Dec 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $12 | $4.05 | +196.30% | 18 | Dec 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $85 | $41.85 | +103.11% | 15 | Dec 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $12 | $1.88 | +538.30% | 15 | Nov 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $20 | $3.00 | +566.67% | 15 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $16 | $2.68 | +497.01% | 13 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $135 | $90.14 | +49.77% | 16 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 | $0.92 | +766.74% | 12 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $5.90 | +86.44% | 8 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $29 | $11.10 | +161.26% | 11 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $4 | $4.35 | -8.05% | 16 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $6 | $3.23 | +85.76% | 11 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $22 | $13.51 | +62.84% | 10 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $1.85 | +710.81% | 10 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $55 | $23.99 | +129.26% | 7 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $6 → $1 | $0.20 | +400.00% | 16 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $21.27 | +41.04% | 12 | Nov 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $17 | $1.70 | +900.00% | 11 | Nov 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $26 | $3.63 | +616.25% | 9 | Nov 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $35 | $1.86 | +1,781.72% | 8 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $27 | $16.87 | +60.05% | 17 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $90 | $21.45 | +319.58% | 19 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $35 | $11.68 | +199.66% | 10 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $90 | $70.44 | +27.77% | 11 | Nov 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $300 | $146.47 | +104.82% | 18 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $400 → $425 | $359.58 | +18.19% | 13 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $35 | $3.19 | +997.18% | 11 | Oct 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $80 | $13.00 | +515.38% | 5 | Sep 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 | $0.96 | +733.51% | 7 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $7.57 | +296.30% | 8 | Aug 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $46 | $40.66 | +13.13% | 6 | Jun 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $7 | $3.95 | +77.22% | 6 | Nov 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $6.00 | +66.67% | 5 | Aug 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $100 → $40 | $2.50 | +1,500.00% | 3 | Feb 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $150 | $0.55 | +27,422.93% | 1 | Jan 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $10 → $3 | $0.46 | +552.17% | 4 | May 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $15 | $4.88 | +207.38% | 1 | Apr 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $80 → $40 | $3.05 | +1,211.48% | 3 | Mar 16, 2022 |
Structure Therapeutics
Dec 20, 2024
Reiterates: Buy
Price Target: $80
Current: $27.90
Upside: +186.74%
Prothena Corporation
Dec 20, 2024
Reiterates: Buy
Price Target: $84 → $48
Current: $15.22
Upside: +215.37%
Vertex Pharmaceuticals
Dec 20, 2024
Maintains: Buy
Price Target: $600 → $535
Current: $397.27
Upside: +34.67%
Avidity Biosciences
Dec 20, 2024
Initiates: Buy
Price Target: $72
Current: $31.82
Upside: +126.27%
Foghorn Therapeutics
Dec 17, 2024
Reiterates: Buy
Price Target: $20 → $13
Current: $5.14
Upside: +152.92%
Annexon
Dec 17, 2024
Reiterates: Buy
Price Target: $30
Current: $5.23
Upside: +473.61%
Neurocrine Biosciences
Dec 16, 2024
Reiterates: Buy
Price Target: $190
Current: $135.42
Upside: +40.30%
Keros Therapeutics
Dec 13, 2024
Reiterates: Buy
Price Target: $100 → $47
Current: $17.03
Upside: +175.98%
ProQR Therapeutics
Dec 12, 2024
Reiterates: Buy
Price Target: $10
Current: $2.63
Upside: +280.23%
TScan Therapeutics
Dec 11, 2024
Reiterates: Buy
Price Target: $15
Current: $2.97
Upside: +405.05%
Dec 11, 2024
Reiterates: Buy
Price Target: $87
Current: $18.48
Upside: +370.78%
Dec 6, 2024
Reiterates: Buy
Price Target: $23
Current: $5.39
Upside: +326.72%
Dec 6, 2024
Reiterates: Buy
Price Target: $20
Current: $8.36
Upside: +139.23%
Dec 5, 2024
Reiterates: Buy
Price Target: $12
Current: $4.05
Upside: +196.30%
Dec 5, 2024
Reiterates: Buy
Price Target: $85
Current: $41.85
Upside: +103.11%
Nov 18, 2024
Reiterates: Buy
Price Target: $12
Current: $1.88
Upside: +538.30%
Nov 15, 2024
Reiterates: Buy
Price Target: $20
Current: $3.00
Upside: +566.67%
Nov 15, 2024
Reiterates: Buy
Price Target: $16
Current: $2.68
Upside: +497.01%
Nov 15, 2024
Reiterates: Buy
Price Target: $135
Current: $90.14
Upside: +49.77%
Nov 15, 2024
Reiterates: Buy
Price Target: $8
Current: $0.92
Upside: +766.74%
Nov 14, 2024
Reiterates: Buy
Price Target: $11
Current: $5.90
Upside: +86.44%
Nov 14, 2024
Reiterates: Buy
Price Target: $29
Current: $11.10
Upside: +161.26%
Nov 14, 2024
Reiterates: Neutral
Price Target: $4
Current: $4.35
Upside: -8.05%
Nov 13, 2024
Maintains: Buy
Price Target: $10 → $6
Current: $3.23
Upside: +85.76%
Nov 13, 2024
Reiterates: Buy
Price Target: $22
Current: $13.51
Upside: +62.84%
Nov 13, 2024
Reiterates: Buy
Price Target: $15
Current: $1.85
Upside: +710.81%
Nov 13, 2024
Reiterates: Buy
Price Target: $55
Current: $23.99
Upside: +129.26%
Nov 13, 2024
Downgrades: Neutral
Price Target: $6 → $1
Current: $0.20
Upside: +400.00%
Nov 8, 2024
Reiterates: Buy
Price Target: $30
Current: $21.27
Upside: +41.04%
Nov 8, 2024
Reiterates: Buy
Price Target: $17
Current: $1.70
Upside: +900.00%
Nov 8, 2024
Reiterates: Buy
Price Target: $26
Current: $3.63
Upside: +616.25%
Nov 7, 2024
Reiterates: Buy
Price Target: $35
Current: $1.86
Upside: +1,781.72%
Nov 7, 2024
Reiterates: Buy
Price Target: $27
Current: $16.87
Upside: +60.05%
Nov 7, 2024
Reiterates: Buy
Price Target: $90
Current: $21.45
Upside: +319.58%
Nov 6, 2024
Reiterates: Buy
Price Target: $35
Current: $11.68
Upside: +199.66%
Nov 1, 2024
Reiterates: Buy
Price Target: $90
Current: $70.44
Upside: +27.77%
Oct 31, 2024
Reiterates: Buy
Price Target: $300
Current: $146.47
Upside: +104.82%
Oct 31, 2024
Maintains: Buy
Price Target: $400 → $425
Current: $359.58
Upside: +18.19%
Oct 24, 2024
Maintains: Buy
Price Target: $25 → $35
Current: $3.19
Upside: +997.18%
Sep 23, 2024
Reiterates: Buy
Price Target: $80
Current: $13.00
Upside: +515.38%
Aug 8, 2024
Reiterates: Buy
Price Target: $8
Current: $0.96
Upside: +733.51%
Aug 6, 2024
Reiterates: Buy
Price Target: $30
Current: $7.57
Upside: +296.30%
Jun 17, 2024
Reiterates: Buy
Price Target: $46
Current: $40.66
Upside: +13.13%
Nov 2, 2023
Maintains: Buy
Price Target: $17 → $7
Current: $3.95
Upside: +77.22%
Aug 15, 2023
Reiterates: Buy
Price Target: $10
Current: $6.00
Upside: +66.67%
Feb 13, 2023
Maintains: Buy
Price Target: $100 → $40
Current: $2.50
Upside: +1,500.00%
Jan 31, 2023
Reiterates: Buy
Price Target: $150
Current: $0.55
Upside: +27,422.93%
May 5, 2022
Downgrades: Neutral
Price Target: $10 → $3
Current: $0.46
Upside: +552.17%
Apr 27, 2022
Assumes: Buy
Price Target: $15
Current: $4.88
Upside: +207.38%
Mar 16, 2022
Maintains: Neutral
Price Target: $80 → $40
Current: $3.05
Upside: +1,211.48%